Citations

Clear

116 citation(s) found for "Colby, Thomas".

Sudden-Onset Fatal Asthma: A Distinct Entity with Few Eosinophils and Relatively More Neutrophils in the Airway Submucosa?
Sur, Sanjiv , Crotty, Thomas B., Kephart, Gail M., Hyma, Bruce A., Colby, Thomas V. , Reed, Charles E., Hunt, Loren W., Gleich, Gerald J.

Mayo Clinic

American Review of Respiratory Disease | August 3, 2011 | Volume: 148 | Issue: 3 | Pages: 713-719

10.1164/ajrccm/148.3.713 | PMID 8368644 Get It

Abstract To determine the histologic differences in the airways of patients who died from sudden-onset asthma and the more common slow-onset asthma, we studied seven cases of fatal asthma. The numbers of eosinophilsand neutrophils, as well as extracellular deposition of their respective granule contents in the airway mucosa and submucosa, were determined and statistically analyzed. Four of the seven patients had slow-onset asthma attacks in which the time interval between onset of asthma and death was more than 2.5 h. In contrast, three patients had sudden-onset asthma in which the time interval between onset of asthma attack and death was less than 1 h. The four patients with slow-onset fatal asthma had more eosinophils (34.1 ± 6.3 in slow-onset; 9.7 ± 3.5 in sudden-onset; p = 0.002) and fewer neutrophils (4.8 ± 2.0 in slow-onset; 16.8 ± 5.4 in sudden-onset; p = 0.008) in the airway submucosa than did patients with sudden-onset fatal asthma. In addition, within the slow-onset fatal asthma group, eosinophils exceeded neutrophils in the airway submucosa (eosinophils > neutrophils, p = 0.002). By contrast, within the sudden-onset fatal asthma group, neutrophils exceeded eosinophils (neutrophils > eosinophils, p = 0.04). We suggest that sudden-onset fatal asthma is immunohistologically distinct from slow-onset fatal asthma and that it is characterized by a relative paucity of eosinophils in the face of an excess of neutrophils in the airway submucosa. These observations raise the possibility that the mechanism of airway inflammation as well as that of airway narrowing in sudden-onset fatal asthma may be quite distinct from those in slow-onset fatal asthma.
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Systematic Overview
Nassar, Adrienne A., Jaroszewski, Dawn E. , Helmers, Richard A. , Colby, Thomas V. , Patel, B. M. , Mookadam, Farouk

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | March 25, 2011 | Volume: 184 | Issue: 1 | Pages: 8-16

10.1164/rccm.201010-1685pp | PMID 21471097 Get It

Abstract Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is being recognized with increasing frequency. Diagnostic and treatment information is limited. A systematic review is presented, focusing on patient demographics, clinical presentation, diagnosis, treatment options, and outcomes. A systematic electronic literature search was conducted for adult DIPNECH cases reported in the English literature during the past 6 years. Twenty-four DIPNECH cases were identified. Another case from our institution is contributed. Women represent 92% (23 of 25). Mean age at diagnosis was 58 years (range, 36–76 yr). Most were nonsmokers (16 of 24). Symptoms included cough (71%), dyspnea (63%), and wheezing (25%) occurring days to years before diagnosis. Pulmonary function testing showed obstructive ventilatory disease in 54%. Lung nodules were seen in 15 patients (63%), ground-glass attenuation in 7 patients (29%), and bronchiectasis in 5 patients (21%). Histological confirmation required surgical lung biopsy for 88%; however, transbronchial biopsies alone were diagnostic in three patients. Treatments strategies included systemic and inhaled corticosteroids, bronchodilators, and lung resection. Available follow-up data in 17 patients showed 6 clinically improved, 7 who remained stable, and 4 clinically deteriorated. The majority of patients presenting with DIPNECH are middle-aged females with symptoms of cough and dyspnea; obstructive abnormalities on pulmonary function testing; and radiographic imaging showing pulmonary nodules, ground-glass attenuation, and bronchiectasis. In general, the clinical course remains stable; however, progression to respiratory failure does occur. Long-term follow-up and treatment remains incomplete. Establishment of a national multicenter DIPNECH registry would allow formulation of optimal evidence-based guidelines for management of these patients.
Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis
Fell, Charlene D. , Liu, Lyrica X., Murray, Susan , Han, MeiLan K., Kazerooni, Ella A. , Gross, Barry H., Colby, Thomas V. , Toews, Galen B., Flaherty, Kevin R. , Martínez, Fernando J. , Han, MeiLan King , Myers, Jeffrey L. , Travis, William D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | January 7, 2010 | Volume: 181 | Issue: 8 | Pages: 832-837

10.1164/rccm.200906-0959oc | PMID 20056903 Get It

Abstract Rationale Idiopathic pulmonary fibrosis (IPF) and other idiopathic interstitial pneumonias (IIPs) have similar clinical and radiographic features, but their histopathology, response to therapy, and natural history differ. A surgical lung biopsy is often required to distinguish between these entities. Objectives We sought to determine if clinical variables could predict a histopathologic diagnosis of IPF in patients without honeycomb change on high-resolution computed tomography (HRCT). Methods Data from 97 patients with biopsy-proven IPF and 38 patients with other IIPs were examined. Logistic regression models were built to identify the clinical variables that predict histopathologic diagnosis of IPF. Measurements and Main Results Increasing age and average total HRCT interstitial score on HRCT scan of the chest may predict a biopsy confirmation of IPF. Sex, pulmonary function, presence of desaturation, or distance walked during a 6-minute walk test did not help discriminate pulmonary fibrosis from other IIPs. Conclusions Clinical data may be used to predict a diagnosis of IPF over other IIPs. Validation of these data with a prospective study is needed.
Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function
Jeong, Yeon Joo , Lee, Kyung Soo , Müller, Néstor L. , Chung, Man Pyo , Chung, Myung Jin , Han, Joungho , Colby, Thomas V. , Kim, Seonwoo

Mayo Clinic

Korean Journal of Radiology | April 20, 2009 | Volume: 6 | Issue: 3 | Pages: 143

10.3348/kjr.2005.6.3.143 | PMID 16145289 Get It

The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
Fell, Charlene D. , Liu, Lyrica Xiaohong, Motika, Caroline, Kazerooni, Ella A. , Gross, Barry H., Colby, Thomas V. , Murray, Susan , Toews, Galen B., Flaherty, Kevin R. , Motika, Caroline A., Travis, William D. , Martínez, Fernando J.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | December 12, 2008 | Volume: 179 | Issue: 5 | Pages: 402-407

10.1164/rccm.200802-241oc | PMID 19074597 Get It

Abstract Rationale Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea, impaired gas exchange, and ultimate mortality. Objectives To test the hypothesis that maximal oxygen uptake during cardiopulmonary exercise testing at baseline and with short-term longitudinal measures would predict mortality in patients with idiopathic pulmonary fibrosis. Methods Data from 117 patients with IPF and longitudinal cardiopulmonary exercise tests were examined retrospectively. Survival was calculated from the date of the first cardiopulmonary exercise test. Measurements and Main Results Patients with baseline maximal oxygen uptake less than 8.3 ml/kg/min had an increased risk of death (n = 8; hazard ratio, 3.24; 95% confidence interval, 1.10–9.56; P = 0.03) after adjusting for age, gender, smoking status, baseline forced vital capacity, and baseline diffusion capacity for carbon monoxide. We were unable to define a unit change in maximal oxygen uptake that predicted survival in our cohort. Conclusions We conclude that a threshold maximal oxygen uptake of 8.3 ml/kg/min during cardiopulmonary exercise testing at baseline adds prognostic information for patients with IPF.
Idiopathic Nonspecific Interstitial Pneumonia
Hunninghake, Gary W., King, Talmadge E. , Lynch, David A. , Colby, Thomas V. , Galvin, Jeffrey R. , Brown, Kevin M. , Chung, Man Pyo , Cordier, Jean-François, Bois, Roland M. du, Flaherty, Kevin R., Franks, Teri J. , Hansell, David M., Hartman, Thomas E. , Kazerooni, Ella A. , Kim, Dong Soon, Kitaichi, Masanori, Koyama, Takashi , Nagai, Sonoko, Midthun, David E. , Müller, Nestor L., Raghu, Ganesh , Selman, Moisés , Wells, Athol U. , Travis, William D. , Flaherty, Kevin R., Martínez, Fernando J. , Nicholson, Andrew G.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2008 | Volume: 177 | Issue: 12 | Pages: 1338-1347

10.1164/rccm.200611-1685oc | PMID 18388353 Get It

Abstract Rationale The 2002 American Thoracic Society/European Respiratory Society classification of idiopathic interstitial pneumonias identified nonspecific interstitial pneumonia (NSIP) as a provisional diagnosis. Concern was expressed that NSIP was a “wastebasket” category, difficult to distinguish from other idiopathic interstitial pneumonias. Objectives The following questions were addressed: (1) Is idiopathic NSIP a distinct entity? 2) If so, what are its clinical, radiologic and pathologic characteristics? (3) What is the role of radiology and pathology in establishing the diagnosis? (4) To make a diagnosis of idiopathic NSIP, what other disorders need to be excluded and how should this be done? Methods Investigators who had previously reported cases of idiopathic NSIP were invited to submit cases for review (n = 305). After initial review, cases with complete clinical, radiologic, and pathologic information (n = 193) were reviewed in a series of workshops. Measurements and Main Results Sixty-seven cases were identified as NSIP. Mean age was 52 years, 67% were women, 69% were never-smokers, and 46% were from Asian countries. The most common symptoms were dyspnea (96%) and cough (87%); 69% had restriction. By high-resolution computed tomography, the lower lung zones were predominantly involved in 92% of cases; 46% had a peripheral distribution; 47% were diffuse. Most showed a reticular pattern (87%) with traction bronchiectasis (82%) and volume loss (77%). Lung biopsies showed uniform thickening of alveolar walls with a spectrum of cellular to fibrosing patterns. Five-year survival was 82.3%. Conclusions Idiopathic NSIP is a distinct clinical entity that occurs mostly in middle-aged women who are never-smokers. The prognosis of NSIP is very good.
Computed Tomography Findings in Pathological Usual Interstitial Pneumonia
Sumikawa, Hiromitsu , Johkoh, Takeshi , Colby, Thomas V. , Ichikado, Kazuya , Suga, Moritaka, Taniguchi, Hiroyuki , Ogura, Takashi , Arakawa, Hiroaki , Fujimoto, Kiminori , Inoue, Atsuo, Mihara, Naoki , Honda, Osamu, Nakamura, Hironobu, Müller, Néstor L. , Kondoh, Yasuhiro , Tomiyama, Noriyuki

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | November 1, 2007 | Volume: 177 | Issue: 4 | Pages: 433-439

10.1164/rccm.200611-1696oc | PMID 17975197 Get It

Abstract Rationale Patients with a clinicopathological diagnosis of idiopathic pulmonary fibrosis (IPF) may have typical findings of usual interstitial pneumonia (UIP) on computed tomography (CT) or nonspecific or atypical findings, including those often seen in nonspecific interstitial pneumonia. Objectives The aims of this study were to revisit the high-resolution CT findings of IPF and to clarify the correlation between the CT findings and mortality. Methods The study included 98 patients with a histologic diagnosis of UIP and a clinical diagnosis of IPF. Two observers evaluated the CT findings independently and classified each case into one of the following three categories: (1) definite UIP, (2) consistent with UIP, or (3) suggestive of alternative diagnosis. The correlation between the CT categories and mortality was evaluated using the Kaplan-Meier method and the log-rank test, as well as Cox proportional hazards regression models. Measurements and Main Results Thirty-three of the 98 CT scans were classified as definite UIP, 36 as consistent with UIP, 29 as suggestive of an alternative diagnosis. The mean survival was 45.7, 57.9, and 76.9 months, respectively. There was no significant difference in survival among the three categories (all P > 0.05). Traction bronchiectasis and fibrosis scores were significant predictors of outcome (hazard ratios: 1.30 and 1.10, respectively; 95% confidence intervals: 1.18–14.2 and 1.03–1.19, respectively). Conclusions In patients with IPF and UIP pattern on the biopsy, the pattern of abnormality on thin-section CT, whether characteristic of UIP or suggestive of alternative diagnosis, does not influence prognosis. Prognosis is influenced by traction bronchiectasis and fibrosis scores.
Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia
Huang, Steven K. , Wettlaufer, Scott H., Hogaboam, Cory M. , Flaherty, Kevin R. , Colby, Thomas V. , Toews, Galen B., Peters‐Golden, Marc , Martínez, Fernando J. , Myers, Jeffrey L. , Travis, William D.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 4, 2007 | Volume: 177 | Issue: 1 | Pages: 66-74

10.1164/rccm.200706-963oc | PMID 17916807 Get It

Abstract Rationale Prostaglandin (PG) E2, a cyclooxygenase-derived lipid mediator, is a potent down-regulator of fibroblast activation in normal lung fibroblasts. Although fibroblasts from patients with idiopathic pulmonary fibrosis are known to exhibit a defect in PGE2 synthesis, there is little information about their responsiveness to this lipid mediator. Objectives To compare responses to PGE2 in normal, usual interstitial pneumonia (UIP), and other diffuse parenchymal lung disease (DPLD) fibroblasts. Methods Fibroblasts were grown in vitro from well characterized control (n = 7), UIP (n = 17), or other DPLD (n = 13) lung tissue. The effects of PGE2 on fibroblast proliferation and collagen expression were determined. Measurements and Main Results Only 3 of 12 UIP fibroblast lines exhibited PGE2-mediated inhibition of both collagen synthesis and cell proliferation, as opposed to 6 of 6 nonfibrotic control cell lines. The degree of PGE2 resistance in DPLD fibroblasts was quite variable, with UIP cells exhibiting the greatest degree of resistance to PGE2, whereas other DPLD fibroblasts manifested a degree of resistance intermediate to control and UIP. The resistance to suppression of collagen expression correlated with worse lung function. Molecular mechanisms for resistance included altered E prostanoid receptor profiles and diminished expression of the downstream kinase, protein kinase A. Conclusions The recognition that UIP fibroblasts manifest variable refractoriness to PGE2 suppression sheds new light on the activation phenotype of these cells and on the pathogenesis of fibrotic lung disease.
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Collard, Harold R. , Moore, Bethany B. , Flaherty, Kevin R. , Brown, Kevin M. , King, Talmadge E. , Lasky, Joseph A. , Loyd, James E. , Noth, Imre , Olman, Mitchell A. , Raghu, Ganesh , Roman, Jesse , Ryu, Jay H. , Zisman, David A., Hunninghake, Gary W., Colby, Thomas V. , Egan, Jim, Hansell, David M., Johkoh, Takeshi , Kaminski, Naftali , Kim, Dong Soon, Lynch, David A. , Müller–Quernheim, Joachim, Selman, Moisés , Toews, Galen B., Wells, Athol U. , Kaner, Robert J. , Kondoh, Yasuhiro , Myers, Jeffrey L. , Nicholson, Andrew G. , Martínez, Fernando J. , Kaminski, Naftali , Ryu, Jay H , Loyd, James E

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | June 21, 2007 | Volume: 176 | Issue: 7 | Pages: 636-643

10.1164/rccm.200703-463pp | PMID 17585107 Get It

Abstract The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.
Idiopathic Interstitial Pneumonia
Flaherty, Kevin R. , Andrei, Adin‐Cristian , King, Talmadge E. , Raghu, Ganesh , Colby, Thomas V. , Wells, Athol U. , Bassily, Nadir, Brown, Kevin K. , Bois, Roland du, Flint, Andrew , Gay, Steven E., Gross, Barry H., Kazerooni, Ella A. , Knapp, Robert H., Louvar, Edmund, Lynch, David A. , Quick, John S., Vyskocil, J , Wadenstorer, Frazer A., Wilt, Jeffrey, Toews, Galen B., Murray, Susan , Nicholson, Andrew G. , Thannickal, Victor J. , Travis, William D. , Martínez, Fernando J.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | January 25, 2007 | Volume: 175 | Issue: 10 | Pages: 1054-1060

10.1164/rccm.200606-833oc | PMID 17255566 Get It

Abstract Rationale Treatment and prognoses of diffuse parenchymal lung diseases (DPLDs) varies by diagnosis. Obtaining a uniform diagnosis among observers is difficult. Objectives Evaluate diagnostic agreement between academic and community-based physicians for patients with DPLDs, and determine if an interactive approach between clinicians, radiologists, and pathologists improved diagnostic agreement in community and academic centers. Methods Retrospective review of 39 patients with DPLD. A total of 19 participants reviewed cases at 2 community locations and 1 academic location. Information from the history, physical examination, pulmonary function testing, high-resolution computed tomography, and surgical lung biopsy was collected. Data were presented in the same sequential fashion to three groups of physicians on separate days. Measurements and Main Results Each observer's diagnosis was coded into one of eight categories. A κ statistic allowing for multiple raters was used to assess agreement in diagnosis. Interactions between clinicians, radiologists, and pathologists improved interobserver agreement at both community and academic sites; however, final agreement was better within academic centers (κ = 0.55–0.71) than within community centers (κ = 0.32–0.44). Clinically significant disagreement was present between academic and community-based physicians (κ = 0.11–0.56). Community physicians were more likely to assign a final diagnosis of idiopathic pulmonary fibrosis compared with academic physicians. Conclusions Significant disagreement exists in the diagnosis of DPLD between physicians based in communities compared with those in academic centers. Wherever possible, patients should be referred to centers with expertise in diffuse parenchymal lung disorders to help clarify the diagnosis and provide suggestions regarding treatment options.